Biogen's $56,000-a-year Alzheimer's drug reignites US debate over costs


Campaigners hit out at high price for controversial treatment that has divided scientists... Read more

Bron: Financial Times - Europe homepage
Tags: Biogen
Geplaatst: 08 Jun 2021 - 06:00